Notice2022-02599
National Cancer Institute; Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 8, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 26 (Tuesday, February 8, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 26 (Tuesday, February 8, 2022)]
[Notices]
[Page 7196]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-02599]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, National Cancer Institute.
A portion of the meeting will be held as a virtual meeting and is
open to the public as indicated below. Individuals who plan to view the
virtual meeting and need special assistance or other reasonable
accommodations to view the meeting, should notify the Contact Person
listed below in advance of the meeting. The open session will be
videocast and can be accessed from the NIH Videocasting and Podcasting
website (<a href="http://videocast.nih.gov/">http://videocast.nih.gov/</a>).
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in sections 552b(c)(6), Title
5 U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the National
Cancer Institute, including consideration of personnel qualifications
and performance, and the competence of individual investigators, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: Board of Scientific Counselors, National
Cancer Institute.
Date: March 7, 2022.
Open: 11:00 a.m. to 11:30 a.m.
Agenda: Remarks from the NCI Director.
Closed: 11:40 a.m. to 3:40 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Name of Committee: Board of Scientific Counselors, National
Cancer Institute.
Date: March 8, 2022.
Closed: 11:00 a.m. to 2:45 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
Place: National Cancer Institute, 9609 Medical Center Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Brian E. Wojcik, Ph.D., Senior Review
Administrator, Institute Review Office, Office of the Director,
National Cancer Institute, National Institutes of Health, 9609
Medical Center Drive, Room 3W414, Rockville, MD 20850, 240-276-5660,
<a href="/cdn-cgi/l/email-protection#a1d6cecbc2c8cac3e1ccc0c8cd8fcfc8c98fc6ced7"><span class="__cf_email__" data-cfemail="31465e5b52585a53715c50585d1f5f58591f565e47">[email protected]</span></a>.
Any interested person may file written comments with the
committee by forwarding the statement to the Contact Person listed
on this notice. The statement should include the name, address,
telephone number and when applicable, the business or professional
affiliation of the interested person.
Information is also available on the Institute's/Center's home
page: <a href="https://deainfo.nci.nih.gov/advisory/bsc/index.htm">https://deainfo.nci.nih.gov/advisory/bsc/index.htm</a>, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 3, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-02599 Filed 2-7-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 8, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.